Advertisement
Product › Details
T cell therapy
Next higher product group | cell therapy | |
Record changed: 2023-07-10 |
Advertisement
More documents for T cell therapy
- [1] |transkript [Kääb, Georg]. (3/19/24). "News: Alles neu bei T-knife: Target, Molekül und Studie"....
- [2] Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto....
- [3] Medigene AG. (2/1/23). "Press Release: Medigene AG Appoints Pamela Keck as Vice President of Investor Relations and Corporate Communications". Planegg....
- [4] Atara Biotherapeutics, Inc.. (12/19/22). "Press Release: Atara Biotherapeutics Announces Changes to Its Board of Directors". Thousand Oaks, CA....
- [5] Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford....
- [6] Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies....
- [7] Bayer AG. (3/22/22). "Press Release: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations". Tel Aviv....
- [8] Quell Therapeutics Ltd.. (1/6/22). "Press Release: Quell Therapeutics Announces Presentation at the 40th Annual J.P. Morgan Healthcare Conference". London & Boston, MA....
- [9] Quell Therapeutics Ltd.. (11/29/21). "Press Release: Quell Therapeutics Raises $156 Million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform". London & Boston,...
- [10] Egle Therapeutics SAS. (10/22/21). "Press Release: Egle Therapeutics Raises 40 million € Series A to Develop First-In-Class T-regulatory Cells Therapies Based on Treg-starvers". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top